Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    Why did this record match?
    Reference Devices :

    K231587, K232535, K213693, K153343

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The MAGNETOM system is indicated for use as a magnetic resonance diagnostic device (MRDD) that produces transverse, sagittal, coronal and oblique cross sectional images, spectroscopic images and/or spectra, and that displays the internal structure and/or function of the head, body, or extremities. Other physical parameters derived from the images and/or spectra may also be produced. Depending on the region of interest, contrast agents may be used. These images and/or spectra and the physical parameters derived from the images and/or spectra when interpreted by a trained physician yield information that may assist in diagnosis.

    The MAGNETOM system may also be used for imaging during interventional procedures when performed with MR compatible devices such as in-room displays and MR Safe biopsy needles.

    Device Description

    The subject device, MAGNETOM Avanto Fit with software syngo MR XA70A, consists of new and modified software and hardware that is similar to what is currently offered on the predicate device, MAGNETOM Avanto Fit with syngo MR XA50A (K220151).

    A high-level summary of the new and modified hardware and software is provided below:

    For MAGNETOM Avanto Fit with syngo MR XA70:

    Hardware

    New Hardware:
    myExam 3D Camera
    BM Head/Neck 20

    Modified Hardware:
    Sanaflex (cushions for patient positioning)

    Software

    New Features and Applications:
    myExam Autopilot Brain
    myExam Autopilot Knee
    3D Whole Heart
    HASTE_interactive
    GRE_PC
    Open Recon
    Deep Resolve Gain
    Fleet Reference Scan
    Physio logging
    complex averaging
    AutoMate Cardiac
    Ghost Reduction
    BLADE diffusion
    Beat Sensor
    Deep Resolve Sharp
    Deep Resolve Boost and Deep Resolve Boost (TSE)
    Deep Resolve Boost HASTE
    Deep Resolve Boost EPI Diffusion

    Modified Features and Applications:
    SPACE improvement (high band)
    SPACE improvement (incr grad)
    Brain Assist
    Eco power mode
    myExam Angio Advanced Assist (Test Bolus)

    The subject device, MAGNETOM Skyra Fit with software syngo MR XA70A, consists of new and modified software and hardware that is similar to what is currently offered on the predicate device, MAGNETOM Skyra Fit with syngo MR XA50A (K220589).

    A high-level summary of the new and modified hardware and software is provided below:

    For MAGNETOM Skyra Fit with syngo MR XA70:

    Hardware

    New Hardware:
    myExam 3D Camera

    Modified Hardware:
    Sanaflex (cushions for patient positioning)

    Software

    New Features and Applications:
    Beat Sensor
    HASTE_interactive
    GRE_PC
    3D Whole Heart
    Deep Resolve Gain
    Open Recon
    Ghost Reduction
    Fleet Reference Scan
    BLADE diffusion
    HASTE diffusion
    Physio logging
    complex averaging
    Deep Resolve Swift Brain
    Deep Resolve Sharp
    Deep Resolve Boost and Deep Resolve Boost (TSE)
    Deep Resolve Boost HASTE
    Deep Resolve Boost EPI Diffusion
    AutoMate Cardiac
    SVS_EDIT

    Modified Features and Applications:
    SPACE improvement (high band)
    SPACE improvement (incr grad)
    Brain Assist
    Eco power mode
    myExam Angio Advanced Assist (Test Bolus)

    The subject device, MAGNETOM Sola Fit with software syngo MR XA70A, consists of new and modified software and hardware that is similar to what is currently offered on the predicate device, MAGNETOM Sola Fit with syngo MR XA51A (K221733).

    A high-level summary of the new and modified hardware and software is provided below:

    For MAGNETOM Sola Fit with syngo MR XA70:

    Hardware

    New Hardware:
    myExam 3D Camera

    Modified Hardware:
    Sanaflex (cushions for patient positioning)

    Software

    New Features and Applications:
    GRE_PC
    3D Whole Heart
    Ghost Reduction
    Fleet Reference Scan
    BLADE diffusion
    Physio logging
    Open Recon
    Complex averaging
    Deep Resolve Sharp
    Deep Resolve Boost and Deep Resolve Boost (TSE)
    Deep Resolve Boost HASTE
    Deep Resolve Boost EPI Diffusion
    AutoMate Cardiac
    Implant suite

    Modified Features and Applications:
    SPACE improvement (high band)
    SPACE improvement (incr grad)
    Brain Assist
    Eco power mode

    The subject device, MAGNETOM Viato.Mobile with software syngo MR XA70A, consists of new and modified software and hardware that is similar to what is currently offered on the predicate device, MAGNETOM Viato.Mobile with syngo MR XA51A (K240608).

    A high-level summary of the new and modified hardware and software is provided below:

    For MAGNETOM Viato.Mobile with syngo MR XA70:

    Hardware

    New Hardware:
    n.a.

    Modified Hardware:
    Sanaflex (cushions for patient positioning)

    Software

    New Features and Applications:
    GRE_PC
    3D Whole Heart
    Ghost Reduction
    Fleet Reference Scan
    BLADE diffusion
    Physio logging
    Open Recon
    Complex averaging
    Deep Resolve Sharp
    Deep Resolve Boost and Deep Resolve Boost (TSE)
    Deep Resolve Boost HASTE
    Deep Resolve Boost EPI Diffusion
    AutoMate Cardiac
    Implant suite

    Modified Features and Applications:
    SPACE improvement (high band)
    SPACE improvement (incr grad)
    Brain Assist
    Eco power mode

    Furthermore, the following minor updates and changes were conducted for the subject devices:

    Low SAR Protocol minor update (for all subject devices but MAGNETOM Skyra Fit): the goal of the SAR adaptive protocols was to be able to perform knee, spine, heart and brain examinations with 50% of the max allowed SAR values in normal mode for head and whole-body SAR. The SAR reduction was achieved by parameter adaptations like Flip angle, TR, RF Pulse Type, Turbo Factor, concatenations. For cardiac clinically accepted alternative imaging contrasts are used (submitted with K232494).

    Implementation of image sorting prepare for PACS (submitted with K231560).

    Implementation of improved DICOM color support (submitted with K232494).

    Needle intervention AddIn was added all subject device (submitted with K232494).

    Inline Image Filter switchable for users: in the subject device, users have the ability to switch the "Inline image filter" (implicite Filter) on or off. This filter is an image-based filter that can be applied to specific pulse sequence types. The function of the filter remains unchanged from the previous device MAGNETOM Sola with syngo MR XA61A (K232535).

    SVS_EDIT is newly added for MAGNETOM Skyra Fit, but without any changes (submitted with K203443)

    Brain Assist received an improvement and is identical to that of snygo MR XA61A (K232535)

    Open Recon is introduced for all systems. The function of Open Recon remains unchanged from the previous submissions (submitted with K221733).

    Lock TR and FA in Bold received a minor UI update

    Implant Suite is newly introduced for MAGNETOM Sola Fit and MAGNETOM Viato.Mobile, but without any changes (submitted with K232535)

    myExam Autopilot Brain and myExam Autopilot Knee are newly introduced for the subject device MAGNETOM AVANTO Fit and are unchanged from previous submissions (submitted with K221733).

    myExam Angio Advanced Assist (Test Bolus) received a bug fixing and minimal UI improvements.

    AI/ML Overview

    The provided text is an FDA 510(k) clearance letter for various MAGNETOM MRI Systems. While it details new and modified software and hardware features, it does not include specific acceptance criteria or a study that "proves the device meets the acceptance criteria" in terms of performance metrics like sensitivity, specificity, or accuracy for a diagnostic task.

    Instead, the document focuses on demonstrating substantial equivalence to predicate devices. This is achieved by:

    • Stating that the indications for use are the same.
    • Listing numerous predicate and reference devices.
    • Detailing hardware and software changes.
    • Mentioning non-clinical tests like software verification and validation, sample clinical images, and image quality assessment to show that the new features maintain an "equivalent safety and performance profile" to the predicate devices.
    • Referencing scientific publications for certain features to support their underlying principles and utility.
    • Briefly describing the training and validation data for two AI features: Deep Resolve Boost and Deep Resolve Sharp, but without performance acceptance criteria or detailed results.

    Therefore, much of the requested information cannot be extracted from this document because it is not a study report detailing clinical performance against predefined acceptance criteria for a specific diagnostic outcome.

    However, I can extract the information related to the AI features as best as possible from the "AI Features/Applications training and validation" section (Page 16).


    Acceptance Criteria and Study Details (Limited to AI Features)

    1. Table of Acceptance Criteria and Reported Device Performance

    FeatureAcceptance CriteriaReported Device Performance
    Deep Resolve Boost(Not explicitly stated in the provided document as specific numerical thresholds, but implied through evaluation metrics.)"The impact of the network has been characterized by several quality metrics such as peak signal-to-noise ratio (PSNR) and structural similarity index (SSIM). Most importantly, the performance was evaluated by visual comparisons to evaluate e.g., aliasing artifacts, image sharpness and denoising levels." (Exact numerical results not provided).
    Deep Resolve Sharp(Not explicitly stated in the provided document as specific numerical thresholds, but implied through evaluation metrics and verification activities.)"The impact of the network has been characterized by several quality metrics such as peak signal-to-noise ratio (PSNR), structural similarity index (SSIM), and perceptual loss. In addition, the feature has been verified and validated by inhouse tests. These tests include visual rating and an evaluation of image sharpness by intensity profile comparisons of reconstructions with and without Deep Resolve Sharp." (Exact numerical results not provided).

    2. Sample size used for the test set and the data provenance

    • Deep Resolve Boost:
      • Test Set Sample Size: Not explicitly stated as a separate "test set" size. The document mentions "training and validation data" for over 25,000 TSE slices, over 10,000 HASTE slices (for refinement), and over 1,000,000 EPI Diffusion slices. It's unclear what proportion of this was used specifically for final testing, or if the "validation" mentioned includes the final performance evaluation.
      • Data Provenance: Retrospective, described as "Input data was retrospectively created from the ground truth by data manipulation and augmentation." Country of origin is not specified.
    • Deep Resolve Sharp:
      • Test Set Sample Size: Not explicitly stated as a separate "test set" size. The document mentions "training and validation" on more than 10,000 high resolution 2D images. Similar to Deep Resolve Boost, it's unclear what proportion was specifically for final testing.
      • Data Provenance: Retrospective, described as "Input data was retrospectively created from the ground truth by data manipulation." Country of origin is not specified.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    This information is not provided in the document. The definition of "ground truth" for the AI features refers to the acquired datasets themselves rather than expert-labeled annotations. Visual comparisons are mentioned as part of the evaluation, but without details on expert involvement or qualifications.

    4. Adjudication method for the test set

    This information is not provided in the document. While "visual comparisons" and "visual rating" are mentioned, no specific adjudication method (e.g., 2+1, 3+1) is described.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    No, a MRMC comparative effectiveness study demonstrating human reader improvement with AI assistance is not described in this document. The focus of the AI features (Deep Resolve Boost and Deep Resolve Sharp) is on image quality enhancement (denoising, sharpness) and reconstruction rather than assisting human readers in a diagnostic task that can be quantified by an effect size.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Yes, the evaluation of Deep Resolve Boost and Deep Resolve Sharp, based on metrics like PSNR, SSIM, and perceptual loss, and "visual comparisons" or "visual rating" appears to be an assessment of the algorithm's performance in enhancing image quality in a standalone capacity, without direct human-in-the-loop interaction for diagnosis.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    • Deep Resolve Boost: "The acquired datasets (as described above) represent the ground truth for the training and validation." This implies the original, full-quality, unaltered MRI scan data. Further, "Input data was retrospectively created from the ground truth by data manipulation and augmentation. This process includes further under-sampling of the data by discarding k-space lines, lowering of the SNR level by addition Restricted of noise and mirroring of k-space data."
    • Deep Resolve Sharp: "The acquired datasets represent the ground truth for the training and validation." Similar to Boost, this refers to original, high-resolution MRI scan data. For training, "k-space data has been cropped such that only the center part of the data was used as input. With this method corresponding low-resolution data as input and high-resolution data as output / ground truth were created for training and validation."

    8. The sample size for the training set

    • Deep Resolve Boost:
      • TSE: more than 25,000 slices
      • HASTE (for refinement): more than 10,000 HASTE slices
      • EPI Diffusion: more than 1,000,000 slices
    • Deep Resolve Sharp: more than 10,000 high resolution 2D images.

    9. How the ground truth for the training set was established

    • Deep Resolve Boost: The ground truth was established by the "acquired datasets" themselves (full-quality MRI scans). The training input data was then derived from this ground truth by simulating degraded images (e.g., under-sampling, adding noise).
    • Deep Resolve Sharp: Similarly, the ground truth was the "acquired datasets" (high-resolution MRI scans). The training input data was derived by cropping k-space data to create corresponding low-resolution inputs.
    Ask a Question

    Ask a specific question about this device

    K Number
    K250436
    Date Cleared
    2025-06-16

    (122 days)

    Product Code
    Regulation Number
    892.1000
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K231587, K231617, K223343, K191040

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The MAGNETOM system is indicated for use as a magnetic resonance diagnostic device (MRDD) that produces transverse, sagittal, coronal and oblique cross-sectional images, spectroscopic images and/or spectra, and that displays, depending on optional local coils that have been configured with the system, the internal structure and/or function of the head, body, or extremities. Other physical parameters derived from the images and/or spectra may also be produced. Depending on the region of interest, contrast agents may be used. These images and/or spectra and the physical parameters derived from the images and/or spectra when interpreted by a trained physician yield information that may assist in diagnosis.

    The MAGNETOM system may also be used for imaging during interventional procedures when performed with MR compatible devices such as in-room displays and MR Safe biopsy needles.

    Device Description

    MAGNETOM Flow.Ace and MAGNETOM Flow.Plus are 60cm-bore MRI systems with quench pipe-free, sealed magnets utilizing DryCool technology. They are equipped with BioMatrix technology and run on Siemens' syngo MR XA70A software platform. The systems include Eco Power Mode for reduced energy and helium consumption. They have different gradient configurations suitable for all body regions, with stronger configurations supporting advanced cardiac imaging. Compared to the predicate device, new hardware includes a new magnet, gradient coil, RF system, local coils, patient tables, and computer systems. New software features include AutoMate Cardiac, Quick Protocols, BLADE with SMS acceleration for non-diffusion imaging, Deep Resolve Swift Brain, Fast GRE Reference Scan, Ghost reduction, Fleet Reference Scan, SMS Averaging, Select&GO extension, myExam Spine Autopilot, and New Startup-Timer. Modified features include improvements for Pulse Sequence Type SPACE, improved Gradient ECO Mode Settings, and Inline Image Filter switchable for users.

    AI/ML Overview

    The provided 510(k) clearance letter and summary describe the acceptance criteria and supporting studies for the MAGNETOM Flow.Ace and MAGNETOM Flow.Plus devices, particularly focusing on their AI features: Deep Resolve Boost, Deep Resolve Sharp, and Deep Resolve Swift Brain.

    Here's a breakdown of the requested information:

    1. Table of Acceptance Criteria and Reported Device Performance

    The document uses quality metrics like PSNR, SSIM, and NMSE as indicators of performance and implicitly as acceptance criteria. Visual inspection and clinical evaluations are also mentioned.

    FeatureQuality Metrics (Acceptance Criteria)Reported Performance (Summary)
    Deep Resolve BoostPeak Signal-to-Noise Ratio (PSNR), Structural Similarity Index (SSIM)Most metrics passed.
    Deep Resolve SharpPSNR, SSIM, Perceptual Loss, Visual Rating, Image sharpness evaluation by intensity profile comparisonsVerified and validated by in-house tests, including visual rating and evaluation of image sharpness.
    Deep Resolve Swift BrainPSNR, SSIM, Normalized Mean Squared Error (NMSE), Visual InspectionAfter successful passing of quality metrics tests, work-in-progress packages were delivered and evaluated in clinical settings with collaboration partners. Potential artifacts not well-captured by metrics were detected via visual inspection.

    2. Sample Sizes Used for the Test Set and Data Provenance

    The document uses "Training and Validation data" and often refers to the datasets used for both. It is not explicitly stated what percentage or how many cases from these datasets were strictly reserved for a separate "test set" and what came from the "validation sets." However, given the separation in slice count, the "Validation" slices for Deep Resolve Swift Brain might be considered the test set.

    • Deep Resolve Boost:
      • TSE: >25,000 slices
      • HASTE: >10,000 HASTE slices (refined)
      • EPI Diffusion: >1,000,000 slices
      • Data Provenance: Retrospectively created from acquired datasets. Data covered a broad range of body parts, contrasts, fat suppression techniques, orientations, and field strength.
    • Deep Resolve Sharp:
      • Data: >10,000 high resolution 2D images
      • Data Provenance: Retrospectively created from acquired datasets. Data covered a broad range of body parts, contrasts, fat suppression techniques, orientations, and field strength.
    • Deep Resolve Swift Brain:
      • 1.5T Validation: 3,616 slices (This functions as a test set for 1.5T)
      • 3T Validation: 6,048 slices (This functions as a test set for 3T)
      • Data Provenance: Retrospectively created from acquired datasets.

    The document does not explicitly state the country of origin for the data.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    The document does not explicitly state the number or qualifications of experts used to establish the ground truth for the test sets. For Deep Resolve Swift Brain, it mentions "evaluated in clinical settings with collaboration partners," implying clinical experts were involved in the evaluation, but details are not provided. For Boost and Sharp, the "acquired datasets...represent the ground truth," suggesting the raw imaging data itself, rather than expert annotations on that data, served as ground truth.

    4. Adjudication Method for the Test Set

    The document does not describe a formal adjudication method (e.g., 2+1, 3+1). For Deep Resolve Swift Brain, it mentions "visually inspected" and "evaluated in clinical settings with collaboration partners," suggesting a qualitative assessment, but details on consensus or adjudication are missing.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    A formal MRMC comparative effectiveness study demonstrating human reader improvement with AI vs. without AI assistance is not described in the provided text. The studies focus on the AI's standalone performance in terms of image quality metrics and internal validation.

    6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was Done

    Yes, standalone performance was done for the AI features. The "Test Statistics and Test Results Summary" for Deep Resolve Boost, Deep Resolve Sharp, and Deep Resolve Swift Brain describe the evaluation of the algorithm's output using quantitative metrics (PSNR, SSIM, NMSE) and visual inspection against reference standards, which is characteristic of standalone performance evaluation.

    7. The Type of Ground Truth Used

    For Deep Resolve Boost, Deep Resolve Sharp, and Deep Resolve Swift Brain, the ground truth used was the acquired high-quality datasets themselves. The input data for training and validation was then retrospectively created from this ground truth by manipulating or augmenting it (e.g., undersampling k-space, adding noise, cropping, using only the center part of k-space). This means the original, higher-quality MR images or k-space data served as the reference for what the AI models should reconstruct or improve upon.

    8. The Sample Size for the Training Set

    • Deep Resolve Boost:
      • TSE: >25,000 slices
      • HASTE: pre-trained on the TSE dataset and refined with >10,000 HASTE slices
      • EPI Diffusion: >1,000,000 slices
    • Deep Resolve Sharp: >10,000 high resolution 2D images
    • Deep Resolve Swift Brain: 20,076 slices

    9. How the Ground Truth for the Training Set Was Established

    For Deep Resolve Boost, Deep Resolve Sharp, and Deep Resolve Swift Brain, the "acquired datasets (as described above) represent the ground truth for the training and validation." This implies that high-quality, fully acquired MRI data was considered the ground truth. The input data used during training (e.g., undersampled, noisy, or lower-resolution versions) was then derived or manipulated from this original ground truth. Essentially, the "ground truth" was the optimal, full-data acquisition before any degradation was simulated for the AI's input.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1